Drugs / Rimiducid (AP1903)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06358430 Background | Dec 2024 → Jan 2029 expected | colorectal cancer | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rimiducid (AP1903) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06358430 ↗ |
| Route | Intravenous | “Given by IV” NCT06358430 ↗ |